NCT01974791

Brief Summary

The broad aim of the study is to implement and evaluate the efficacy of Graded Exposure Treatment (GET Living) to target elevated pain-related fears in children with chronic pain. Pain-related fear is an important psychological factor associated with poor outcomes in children suffering with chronic pain. To examine the efficacy of GET Living in addressing pain-related fears the investigators propose to use a sequential replicated randomized single-case experimental phase design with multiple measures. The specific aims are to 1) evaluate the effectiveness and acceptability of individually tailored GET Living for children with high pain-related fear and functional disability and 2) define anatomical and resting state connectivity patterns in the brains of children and adolescents with complex chronic pain prior to and after participation in GET Living.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable chronic-pain

Timeline
Completed

Started Oct 2013

Longer than P75 for not_applicable chronic-pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2013

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

October 22, 2013

Completed
13 days until next milestone

First Posted

Study publicly available on registry

November 4, 2013

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2018

Completed
Last Updated

March 29, 2018

Status Verified

March 1, 2018

Enrollment Period

4.3 years

First QC Date

October 22, 2013

Last Update Submit

March 27, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Decrease in Fear of Pain

    Decrease in Fear of Pain from Baseline to end of treatment at 6-weeks, on average

Secondary Outcomes (5)

  • Decrease in Functional Disability

    Decrease in Functional Disability from Baseline to end of treatment at 6-weeks, on average

  • Improvement in School Functioning

    Improvement in School Functioning from baseline to end of treatment at 6-weeks, on average

  • Decrease in Pain Catastrophizing

    Decrease in Pain Catastrophizing from baseline to end of treatment at 6-weeks, on average

  • Decrease in Pain Intensity

    Decrease in Pain Intensity from baseline to end of treatment at 6-weeks, on average

  • Increase in Physical Activity

    Increase in Physical Activity from baseline to end of treatment at 6-weeks, on average

Study Arms (1)

GET Living Treatment

EXPERIMENTAL
Behavioral: GET Living

Interventions

GET LivingBEHAVIORAL

GET Living is an exposure based treatment jointly delivered by a cognitive-behavioral therapist and physical therapy to help children and adolescents suffering with chronic pain and headache progressively return to valued life activities.

GET Living Treatment

Eligibility Criteria

Age8 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Pain-related fear (score \>40 on the Fear of Pain Questionnaire (FOPQ (Simons et al., 2011a))
  • Musculoskeletal, neuropathic limb or back pain, or headache
  • Functional limitations (score \> 12 on the Functional Disability Inventory (FDI (Kashikar-Zuck et al., 2001; Walker and Greene, 1991)).

You may not qualify if:

  • Significant cognitive impairment (e.g., intellectual disability)
  • Serious psychopathology (e.g., active suicidality).
  • Acute trauma (e.g., spondylolithesis, disk herniation, fracture, acute tendonitis)
  • Systemic disease in active inflammatory state
  • Biomechanical deficit that would limit ability to engage in exposure activities (e.g. severe muscle atrophy)
  • Making gains in current physical therapy or have not had physical therapy, but it is clearly indicated

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Boston Children's Hospital Waltham

Waltham, Massachusetts, 02453, United States

Location

Related Publications (2)

  • Schemer L, Hess CW, Van Orden AR, Birnie KA, Harrison LE, Glombiewski JA, Simons LE. Enhancing Exposure Treatment for Youths With Chronic Pain: Co-design and Qualitative Approach. J Particip Med. 2023 Mar 9;15:e41292. doi: 10.2196/41292.

  • Beebe JA, Kronman C, Mahmud F, Basch M, Hogan M, Li E, Ploski C, Simons LE. Gait Variability and Relationships With Fear, Avoidance, and Pain in Adolescents With Chronic Pain. Phys Ther. 2021 Apr 4;101(4):pzab012. doi: 10.1093/ptj/pzab012.

MeSH Terms

Conditions

Chronic PainNeuralgiaMusculoskeletal PainHeadache

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesMuscular DiseasesMusculoskeletal Diseases

Study Officials

  • Laura E Simons, PhD

    Boston Children's Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Staff Psychologist

Study Record Dates

First Submitted

October 22, 2013

First Posted

November 4, 2013

Study Start

October 1, 2013

Primary Completion

January 1, 2018

Study Completion

January 1, 2018

Last Updated

March 29, 2018

Record last verified: 2018-03

Locations